Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.

Deryugina EI, Zajac E, Juncker-Jensen A, Kupriyanova TA, Welter L, Quigley JP.

Neoplasia. 2014 Oct 23;16(10):771-88. doi: 10.1016/j.neo.2014.08.013. eCollection 2014 Oct.

2.

Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.

Zajac E, Schweighofer B, Kupriyanova TA, Juncker-Jensen A, Minder P, Quigley JP, Deryugina EI.

Blood. 2013 Dec 12;122(25):4054-67. doi: 10.1182/blood-2013-05-501494. Epub 2013 Oct 30.

3.

Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination.

Juncker-Jensen A, Deryugina EI, Rimann I, Zajac E, Kupriyanova TA, Engelholm LH, Quigley JP.

Cancer Res. 2013 Jul 15;73(14):4196-211. doi: 10.1158/0008-5472.CAN-12-4495. Epub 2013 May 16.

4.

Spontaneous metastasis in congenic mice with transgenic breast cancer is unaffected by plasminogen gene ablation.

Almholt K, Juncker-Jensen A, Lærum OD, Johnsen M, Rømer J, Lund LR.

Clin Exp Metastasis. 2013 Mar;30(3):277-88. doi: 10.1007/s10585-012-9534-9. Epub 2012 Sep 21.

PMID:
22996753
5.

No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer.

Cramer EP, Glenthøj A, Häger M, Juncker-Jensen A, Engelholm LH, Santoni-Rugiu E, Lund LR, Laerum OD, Cowland JB, Borregaard N.

PLoS One. 2012;7(6):e39646. doi: 10.1371/journal.pone.0039646. Epub 2012 Jun 21.

6.

Phenotypic overlap between MMP-13 and the plasminogen activation system during wound healing in mice.

Juncker-Jensen A, Lund LR.

PLoS One. 2011 Feb 4;6(2):e16954. doi: 10.1371/journal.pone.0016954.

7.

Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.

Juncker-Jensen A, Rømer J, Pennington CJ, Lund LR, Almholt K.

Mol Carcinog. 2009 Jul;48(7):618-25. doi: 10.1002/mc.20503.

PMID:
19058297
8.

Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model.

Almholt K, Juncker-Jensen A, Laerum OD, Danø K, Johnsen M, Lund LR, Rømer J.

Mol Cancer Ther. 2008 Sep;7(9):2758-67. doi: 10.1158/1535-7163.MCT-08-0251.

9.

Extracellular proteolysis in transgenic mouse models of breast cancer.

Almholt K, Green KA, Juncker-Jensen A, Nielsen BS, Lund LR, Rømer J.

J Mammary Gland Biol Neoplasia. 2007 Mar;12(1):83-97. Review.

10.

Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.

Juncker-Jensen A, Lykkesfeldt AE, Worm J, Ralfkiaer U, Espelund U, Jepsen JS.

Growth Horm IGF Res. 2006 Aug;16(4):224-39. Epub 2006 Aug 8.

PMID:
16893667

Supplemental Content

Loading ...
Support Center